Welcome to YLOAN.COM
yloan.com » Medical » Prospects for cureently antitubercular drugs
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Prospects for cureently antitubercular drugs

1. World Health Organisation: Global Tuberculosis Control:Surveillance

, Planning, Financing. WHO Report 2004.ISBN 92 4 156264 1. 2004. Geneva, Switzerland.2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG,Raviglione MC, Dye C: The growing burden of tuberculosis:global trends and interactions with the HIV epidemic.Arch Intern Med 2003, 163:1009-1021.3. Espinal MA: The global situation of MDR-TB. Tuberculosis 2003,83:44-51.4. O'Brien RJ, Nunn PP: The need for new drugs againsttuberculosis. Obstacles, opportunities, and next steps.Am J Respir Crit Care Med 2001, 163:1055-1058.5. Global Alliance for TB Drug Development: Tuberculosis.Scientific blueprint for tuberculosis drug development.Tuberculosis 2001, 81(Suppl 1):152.6. Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A,Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A et al.:Rifapentine and isoniazid once a week versus rifampicin andisoniazid twice a week for treatment of drug-susceptiblepulmonary tuberculosis in HIV-negative patients: arandomised clinical trial. Lancet 2002, 360:528-534.7. Weiner M, Burman W, Vernon A, Benator D, Peloquin CA,Khan A, Weis S, King B, Shah N, Hodge T et al.: Low isoniazidconcentrations and outcome of tuberculosis treatmentwith once-weekly isoniazid and rifapentine. Am J RespirCrit Care Med 2003, 167:1341-1347.8. Dietze R, Teixeira L, Rocha LM, Palaci M, Johnson JL, Wells C,Rose L, Eisenach K, Ellner JJ: Safety and bactericidal activity ofrifalazil in patients with pulmonary tuberculosis. AntimicrobAgents Chemother 2001, 45:1972-1976.

Prospects for cureently antitubercular drugs

By: Dr Izharul Hasan
Bioform Medical, Inc.-detailed Product Pipeline Why Medical Practitioners Can Consider Joining The Medical Billing Service? Pre-employment Drug Testing Phentermine Diet Pills That Work- Is Most Preferred Weight Loss Drug Control of Occupational Exposures to Hazardous drugs Medical doctor to Octomom in Trouble Why Hgh Is The Ultimate Antiaging Medicine? Recent Custom medical cabinetry San Jose Have You Been The Victim Of Medical Malpractice Medical Contraindications of Surfing That You Should Know Hazardous Drugs and Occupational exposures to Hazardous drugs Exposures to Hazardous drugs and the threat to the Mankind Private Drug Treatment Centers
print
www.yloan.com guest:  register | login | search IP(216.73.216.15) California / Anaheim Processed in 0.016659 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 4 , 1651, 92,
Prospects for cureently antitubercular drugs Anaheim